Correlation between age and telomere length (TL) according to sex. by Chul-young Bae (14709766)

Association between biological age (BA) and telomere age (TMA). by Chul-young Bae (14709766)

Association between biological age (BA) and telomere age (TMA). by Chul-young Bae (14709766)

The serum concentrations of cytokines between good responders and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Association between screen time and demographic variables of respondents (n = 259). by Isha Aryal (22582068)

Demographic data and baseline characteristics between good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

A brief illustration of the revisions between AJCC TNM eighth and ninth editions. by Aihong Zheng (20571034)

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”

<i>Leptospira interrogans</i> from Okinawa induces epithelial barrier disruption with different kinetics. by Tetsuya Kakita (4922584)

Comparison of SD method scores between three ECDs (<i>n</i> = 34; *<i>p</i> < 0.05 using Friedman test with Bonferroni’s correction). by Yong-Rae Kim (19797278)

The difference in NCDs metabolic risk factors’ prevalence between the two surveys. by Mehran Asadi-Aliabadi (8383110)

Dynamics of pairwise net spillovers between sectors in the second stage (in- epidemic). by Cuicui Liu (1496260)

Topographic maps of difference in alpha functional connectivity between breathing conditions. by Anita B. Frohlich (20660615)

Difference in theta power between breathing conditions for frontal midline ROI. by Anita B. Frohlich (20660615)

Topographic maps of difference in theta functional connectivity between breathing conditions. by Anita B. Frohlich (20660615)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects: